North Carolina Newspapers

10 THURSDAY, SEPTEMBER 25, 2003 Report says more heading south Climate , economy reasons for trend BY KAVITA PILLAI STAFF WRITER A report by the U.S. Census Bureau, based on findings from the 2000 Census, shows that the South has attracted more state-to-state migrants than any other region since 1995. The South has become an attractive destination for U.S. res idents on the move because of the region’s growing economy and warm climate, experts say. Laurence Basirico, Elon University sociology professor, said people are leaving the North to escape large metropolitan areas. “(Americans) are becoming dis illusioned with the bigger cities in the North, the congestion, the higher prices," he said. Others might move to the South for economic opportunity, said Pregnant ? You don’t have to make this difficult decision alone. All Services Free and Confidential . • Free pregnancy tests • Positive options 7 V \ • Medical and community referrals I ] Dr R • Compassionate post abortion support v" B 1 PREGNANCY A SUPPORT SERVICES 431 W. Franklin St., Ste 23, Chapel Hill, NC 27516 (919) 942-7318 pss@pregnancysupport.org M, Tu, W, Fl 2 noon - spm; Thurs 3pm - Bpm 'Wr* ** 4/ THURSDAY. OCTOBER 9, 5 P. M. How Children Schooled Political Philosophy: Locke. Rousseau, and Kant on Education and Liberty Frances Ferguson, GlaxoSmithKline Senior Fellow. ■ National Humanities ( enter; Mary Elizabeth Garrett - BnVHhlk' Professor of Arts and Sciences. Johns Hopkins University ‘ o The Greatest Fight ot Our Generation: Joe Louis. ’’Ur-, , ;• */ Y Max Schmeling. and the Transnational Politics ot Boxing \ , JBF v> Lewis Erenberg, Frank H. Kenan Fellow, National £ 'JLaAJ '>* " Humanities Center; Professor of History, Loyola University W .11 ■ Digitizing the Past: Possibilities and Problems '* v K Rov Rosenzweig. 200.i Richard U” Lyman Award Recipient; College of Arts and Sciences Distinguished Professor of History, f George Mason DECEMBER 5 Medieval Spaces and Virtual Space Stephen Murray. Henry Luce Senior Fellow. National Humanities ' ■* SEPTEMBER 1-OCTOBER 24 ' A Photographic Study Y m Mixed Photographic Works on Paper ■W by John M. Hall, New York, New York ’ A ( * OCTOBER 27-DECEMBER 19 * ■ Art for Architecture: new work Mixed Media by Roger Haile Mebane, North Carolina i®-/ ** 181 k f _ These events free ana open to trie public, are supported by the North Carolina W W < GlaxoSmithKi re Educational and Cultural Out'each Endowment Fona J T 'Zr* > It 7 Alexander Dr. • Research Triangle Park, NC • 27709-2256 * ™i f™ *' 919-549-0661 • www.nhc.rtp.nc.us c fNT4 > Pepo-Provera’ [Contraceptive Injection] medroxyprogesterone acetate injectable suspension DEPO-PROVERA Contraceptive Injection (medroxyprogesterone acetate injectable suspension, USP) This product is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases. What is DEPO-PROVERA Contraceptive Injection? DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an intramuscular injection (a shot) in the buttock or upper arm once every 3 months (13 weeks). To continue your contraceptive protection, you must return for your next injection promptly at the end of 3 months (13 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a chemical similar to (but not the same as) the natural hormone progesterone, which is produced by your ovaries dunng the second half of your menstrual cycle DEPO-PROVERA acts by preventing your egg cells from opening. If an egg is not released from the ovanes dunng your menstrual cycle, it cannot become fertilized by sperm and result in pregnancy DEPO-PROVERA also causes changes in the lining of your uterus that make rt less likely Cor pregnancy to occur How effective is DEPO-PROVERA Contraceptive Injection? The efficacy of DEPO PROVERA Contraceptive Injection depends on following the recommended dosage schedule exactly (see 'How often do I get my shot of DEPO-PROVERA Contraceptive Injection?*) To make sure you are not pregnant when you first get DEPO-PROVERA Contraceptive Injection, your first injection must be given ONLY during the first 5 days of a normal menstrual period: ONLY within the first 5 days after childbirth if not breast-feeding: and, if exclusively breast-feeding, ONLY at the sixth week after childbirth. It is a long term injectable contraceptive when administered at 3-month (13-week) intervals DEPO-PROVERA Contraceptive Injection is over 99% effective, making it one of the most reliable methods of birth control available This means that the average annual pregnancy rate is less than one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive methods depends in part on how reliably each woman uses the method The effectiveness of DEPO-PROVERA depends only on the patient returning every 3 months (13 weeks) for her next injection Your health-care provider will help you compare DEPO-PROVERA with other contraceptive methods and give you the information you need in order to decide which contraceptive method is the nght choice for you. The following table shows the percent of women who got pregnant while using different kinds of contraceptive methods. It gives both the lowest expected rate of pregnancy (the rate expected m women who use each method exactly as it should be used) ana the typical rate of pregnancy (which includes women who became pregnant because they forgot to use their birth control or because they did not follow the directions exactly) Percent of Women Experiencing an Accidental Pregnancy in the First Year of Continuous Uee Lowest Method Expected Typical DEPO PROVERA 03 03 Implants (Norplant; 0.2* 0.2* Female stent nation 02 0.4 Male sterilization Q l oTs Oral contraceptive (pill) -3 Combined 0.1 Progestogen only 0.5 iud : 3 Progestasert 2.0 Copper T 380A 08 Condom (without spermicide) 2 12 Diaphragm (with spermicide) 6 i"I Cervical cap 6 18 Withdrawal 4 18 Penodic abstinence L 9 20 Spermicide alone 3 21 Vaginal Sponge used before childbirth 6 18 used after childbirth 9 28 No method 85 85 Source Trussed et at. Obsfef Gynecol 1990:76:558-567 •From Norplant* package insert Who should not use DEPO-PROVERA Contraceptive Injection? Not all women should use DEPO-PROVERA You should not use DEPO-PROVERA if you have any of the following conditions: • if you think you might be pregnant • if you have any vaginal Weeding without a known reason John Hodges-Copple, regional planning director at the Triangle J Council of Governments. “There has been a long-term trend that the Sun Belt has been growing, partly due to growing biotechnology and telecommuni cation industries,” he said. Hodges-Copple also said the retirement community might be attracted to Southern states by the warmer climate. North Carolina in particular has experienced a large population surge in recent years, said Bob Coats, Gov. Mike Easley’s Census liaison. “North Carolina had the fourth largest population growth percent age-wise of any state,” he said. Much of this growth resulted from an influx of foreigners, espe cially those of Hispanic origin. The growth of industry in Research Triangle Park has creat ed anew service industry, Coats said. More jobs in service indus tries are attractive to a largely une ducated, foreign population. B>irth oorvtrol you -tKirik ae-ou-t jus-t 4-x a year • if you have had cancer of the breast • if you have had a stroke • if you have or have had blood clots (phlebitis) m your legs • if you have problems with your liver or liver disease • if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other ingredients). What other things should I consider before using DEPO-PROVERA Contraceptive Injection? You will have a physical examination before your doctor presenbes DEPO-PROVERA It is important to tell your health-care provider if you have any of the following • a family history of breast cancer • an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or bleeding from your nipples • kidney disease • irregular or scanty menstrual penods • high blood pressure • migraine headaches • asthma • epilepsy (convulsions or seizures) • diabetes or a family history of diabetes • a history of depression • if you are taking anv prescnption or over-the-counter medications This product is intended to prevent pregnancy. It does not protect against transmission of HIV (AIDS) and other sexually transmitted diseases such as chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. What if I want to become pregnant after using DEPO-PROVERA Contraceptive Injection? Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last injection for its effect to wear off. Based on the results from a large study done in the United States, for women who stop using DEPO-PROVERA in order to become pregnant it is expected that about half of those who become pregnant will do so in about 10 months after their last injection, about two thirds of those who become pregnant will do so in about 12 months, about 83% of those who become pregnant will do so in about IS months: and about 93% of those who become pregiant will do so m about 18 months after their last injection The length of time you use DEPO-PROVERA has no effect on how longit takesyou to become pregpant after you stop using it What are the risks of using DEPO-PROVERA Contraceptive Injection? 1 Irregular Menstrual Bleeding The side effect reported most frequently by women who use DEPO-PROVERA for contraception is a change in their normal menstrual cycle. Dunng the first year of using DEPO-PROVERA. you might have one or more of the following changes irregular or unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or no bleeding at all Unusually heavy ex continuous bleeding, however, is not a usual effect of DtPO PROVERA; and if this happens, you should see your hearth-care provider nght away With continued use of DEPO-PROVfcRA, bleeding usually decreases, and many women stop having penods completely In clinical studies of DEPO-PROVERA 55% of the women studied reported no menstrual bleeding (amenorrhea) after I year of use. and 68% of the women studied reported no menstrual bleeding after 2 years of use The reason that your penods stop is because DEPO PROVERA causes a resting state in your ovanes. When your ovanes do not release an egg monthly, the regular monthly growth of the lining of your uterus does not occur and. therefore, the bleeding that comes with your normal menstruation does not take place When you stop using DEPO-PROVERA your menstrual penod will usually, in time, return to its normal cycle. 2 Bone Mineral Changes Use of DEPO-PROVERA may be associated with a decrease in the amount of mineral stored in your bones. This could increase your risk of developing bone fractures The rate of bone mineral loss is greatest m the early years of DEPO-PROVERA use. but after that, it begins to resemble the normal rate of age-related bone mineral loss. 3.Concer Studies of women who have used different forms of contraception found that women who used DEPO-PROVERA for contraception had no increased overall nsk of developing cancer of the breast ovary uterus, cervix, or liver However women under 35 years of age whose first exposure to DEPO-PROVERA was within the previous 4 to 5 years may have a slightly increased nsk of developing breast cancer similar to that seen with oral contraceptives You should discuss this with your hearth-care provider 4 Unexpected Pregnancy Because DEPO-PROVERA is such an effective contraceptive method, the nsk of accidental pregnancy for women who get their shots regularly (every 3 months [l3 weeks]) is very low. While there have been reports of an increased nsk of low birth weight and neonatal infant death or other health problems in infants conceived close to the time of injection, such pregnancies are uncommon. If you think you may have become pregnant while using DEPO PROVERA for contraception, see your health-care provider as soon as possible 5 Allergic Reactions Some women using DEPO-PROV c RA Contraceptive Injection have reported severe and potentially life-threatening allergic leactions known as anaphylaxis and anaphylactoid reactions. Symptoms include the sudden onset of hives or swelling and itching of the skin, breathing difficulties, and a drop in blood pressure From Page One “There has been a long-term trend that the Sun Belt has been growing, partly due to growing... industries.” JOHN HODGES-COPPLE, TRIANGLE J COUNCIL OF GOVERNMENTS The increase in the Hispanic population in North Carolina could result in a need for more services that cater to a Spanish speaking community, Basirico said. “Obviously, there will be a need for more (English as a second lan guage) education,” he said. “Bilingualism in schools could also be an issue.” In addition, although blacks had been migrating to Northern states for decades, the South has seen a significant number of blacks returning, Hodges-Copple said. The census report also showed U.S. residents in general are on the move 46 percent moved to a dif ferent home between 1995 and 2000. Military and metropolitan areas often lead the list in having high proportions of inmigrants. Jacksonville had the highest per centage of inmigrants in the coun try because of the number of mili tary personnel in the area. Basirico said the mobility of the U.S. population is a sign of chang ing job markets and family struc tures. People move to find new job opportunities and are less tied down due to a high divorce rate. No matter the specific cause, experts say, growth in the South likely will continue through the next decade. Contact the State & National Editor at stntdesk@unc.edu. INTERNATIONAL FROM PAGE 1 provost, he said, he plans to meet and get to know the people with whom he will work directly, including personnel in the Study Abroad Office and the Carolina Population Center. “I expect to work pretty closely with relevant parties from now on,” he said. “All of the programs that have international dimen sions will cross my path in one way 6 Other Risks Women who use hormone-based contraceptives may have an increased risk of blood dots or stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin to develop outside of the uterus (ectopic pregnancy) While these events are rare, you should tell your hearth-care provider if you have any of the problems listed in the next section What symptoms may signal problems while using DEPO-PROVERA Contraceptive Injection? Call your health-care provider immediately if any of these problems occur following an injection of DEPO-PROVERA • sharp chest pain, coughing up of Wood, or sudden shortness of breath (indicating a possible clot in the lung) • sudden severe headache or vomiting, dizziness or fainting, problems with your eyesight or speech, weakness, or numbness in an arm or leg (indicating a possible stroke) • severe pain or swelling in the calf (indicating a possible clot in the leg) • unusually heavy vaginal Weeding • severe pain or tenderness in the lower abdominal area • persistent pain, pus. or Weeding at the injection site What are the possible side effects of DEPO-PROVERA Contraceptive Injection? 1 Weight Gam You may experience a weight gam while you are using DEPO-PROVERA About two thirds of the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds dunng the first year of use You may continue to gain weight after the first year Women in one large study who used DEPO-PROVERA for 2 years gamed an average total of 8.1 pounds over those 2 years, or approximately 4 pounds per year Women who continued for 4 years gained an average total of Ipounds over those 4 years, or approximately 3.5 pounds per year Women who continued for 6 years gamed an average total of 16.5 pounds over those 6 years, or approximately 2 75 pounds per year 2 Other Side Effects In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some women reported the following effects that may or may not have been related to their use of DEPO-PROVERA: Irregular menstrual Weeding, amenorrhea, headache, nervousness, abdominal cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vaginal discharge or irritation, breast swelling and tenderness. bloating. swelling of the hands or feet, backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss. rash, hot flashes, and joint pain. Other proWems were reported by very few of the women in the clinical tnals. but some of these could be serious. These include convulsions, jaundice, urinary tract infections, allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertility, deep vein thrombosis, pulmonary embolus, breast cancer, or cervical cancer If these or any other problems occur dunng your use of DEPO-PROVERA. discuss them with your health-care provider Should any precautions be followed during use of DEPO-PROVERA Contraceptive Injection? 1 Missed Penods Dunng the time you are using DEPO-PROVERA for contraception, you may skip a penod, or your penods may stop completely If you have been receiving your DEPO PROVERA injections regularly every 3 months (13 weeks), then you are probably not pregnant. However if you think that you may be pregnant, see your health-care provider. 2 Laboratory Test Interactions If you are scheduled for any laboratory tests, tell your health-care provider that you are using DEPO-PROVERA for contraception. Certain Wood tests are affected by hormones such as DEPO PROVERA. 3. Interactions Cytadren (aminoglutethirrude) is an anticancer drug that may significantly decrease the effectiveness of DEPO-PROVERA if the two drugs are given dunng the same time. 4. Nursing Mothers Although DEPO-PROVERA can be passed to the nursing infant in the breast milk, no harmful effects nave been found in these children DEPO-PROVERA does not prevent the breasts from producing milk, so it can be used by nursing mothers. However to minimize the amount of DEPO-PROVERA that is passed to tne infant in the first weeks after birth, you should wait until 6 weeks after childbirth before you start using DEPO-PROVERA for contraception. How often do I get my shot of DEPO-PROVERA Contraceptive Injection? The recommended dose of DEPO-PROVERA is 150 mg every 3 months (13 weeks) given in a single intramuscular injection in the buttock or upper arm. To make sure that you are not pregnant at the time of the first injection, it is essential that the injection be given ONLY dunng the first 5 days of a normal menstrual penod. If used following the delivery of a child, the first injection of DEPO-PROVERA MUST be given within 5 days after childWrth if you are not breast-feeding or 6 weeks after childbirth if you are exclusively breast-feeding. If you wait longer than 3 months (13 weeks) between injections, or longer than 6 weeks after delivery, your health-care provider should determine that you are not pregnant before giving you your injection of DEPO-PROVERA Rx only CB-7-S Pharmacia & Upjohn Company Kalamazoo. Ml 49001, USA RELIEF FROM PAGE 1 ECSU. Young said the facilities services division at UNC-CH saw an over whelming response from workers and sent 12 electricians. “I had a lot more than 12 people who volunteered, and I had to turn down a lot,” Young said. UNC-CH’s Grounds Services also had a positive response and sent 10 groundskeepers to assist ECSU with clearing debris and trees. “There was a need, and I’m really proud of the way the guys responded,” Grounds Director Kirk Pelland said. Most of the volunteer workers are helping to restore power and remove debris along with fallen trees so students can move back into their residence halls. Workers took whole-tree chip pers, two dump trucks and a van full of chain saws to aid in clearing debris. “We have experienced both (Hurricanes) Fran and Floyd on our campus,” said Carolyn Elfland, associate vice chancellor for cam pus services. “Our employees know how to tackle the problems left by a hurricane. ... I’m sure they are or another.” Coclanis said he sees his job’s goal as making the University’s pre-existing international pro grams more visible on campus and around the state. “I will try to create a whole that is greater than the sum of the indi vidual parts,” he said. “I think the University has a much bigger story to tell than what has been heard.” Coclanis will build on UNC’s already strong international force, including the Kenan Institute Asia, a multiuniversity learning center in Bangkok, Thailand. In addition to strengthening those programs, Coclanis said, he will look for other ways for UNC to further its international scope. Until he starts in his new posi tion, Coclanis will continue teach ing his history class and will remain department chairman. He said he wants to continue teaching in the future, but Shelton said that for now, he will cease formal teaching. The associate provost position is funded by a $1 million donation from an anonymous source. The establishment of the inter national affairs jxisition fills one of six priorities to extend UNC’s presence abroad outlined in the campus academic plan, which lists the University’s top priorities for the next five years. The position will focus on the organization of foreign interac tions with the University. Earlier this month, Margie Crowell was selected to serve as associate provost for international programs —a position that will report directly to Coclanis. The search was narrowed to four candidates this month. John Akin, chairman of the Department of Economics; Patrick Conway, professor of economics; and Gail Henderson, professor of social medicine, also were considered. Chancellor James Moeser said of the decision, “Peter is not only a great scholar, but he is much loved by students, too, because he is a great teacher.” Contact the University Editor at udesk@unc.edu. P Pharmacia & Upjohn QJljp ioily (Ear Uppl “(The volunteer workers) are doing a great job. ...We couldn’t recover without them.” BEN HUNTER, ECSU EMPLOYEE doing an outstanding job.” Workers were provided with meals, cots, blankets and other basic supplies in ECSU’s gymnasi um. “They had excellent attitudes about everything, even the sleep ing quarters,” Young said. Facilities services electricians returned to campus Tuesday after marking out and repairing most of the facility and parking lot lights at ECSU. Groundskeepers continued clearing debris and providing assistance at ECSU on Wednesday The groundskeepers are expected back today. “(The workers) are doing a great job,” said Ben Hunter, who works for facilities management at ECSU. “We could n’t recover without them.” Contact the University Editor at udesk@unc.edu. HOGAN FROM PAGE 1 ment on the case. Johnston appealed his Honor Court sanction to the University Hearings Board, where it was reduced to a one-semester suspen sion, John Hogan said. Johnstcn again appealed his sanction, sending the case to Chancellor James Moeser, who upheld the UHB decision, John Hogan said. Moeser declined to comment on the case. Johnston then made his final appeal, John Hogan said, bringing the sanction before the BOT, where it was remanded. Contact the University Editor at tulesk@unc.edu. BOWLES FROM PAGE 1 vacated by Jesse Helms, Bowles lost to Republican candidate Elizabeth Dole, who received 54 percent of the vote compared with Bowles’ 45 percent. The possibility of another Bowles run increased greatly when Edwards announced earlier this month that he is foregoing a Senate re-election bid to focus on his presidential campaign. Bowles and Dan Blue, former speaker of the N.C. House, vied for the Democratic nomination in 2002 and are expected to do so again. U.S. Rep. Richard Burr of Winston-Salem already has been established as the leading GOP candidate in the race. McCorkle said Bowles is talking to Gary Pierce, a media strategist and adviser to Edwards during his 1998 Senate campaign. Geoff Garin, Bowles’ pollster in 2002, also is in the mix of potential con sultants. While Dole stirred up an “exceptionally strong” Republican turnout in the last election, Bowles actually garnered more votes than Edwards did in his successful 1998 run, said Ferrel Guillory, director of UNC’s Program on Southern Politics, Media and Public Life. “(Bowles is) in a strong position to begin a second campaign." He added that to some extent, the upcoming Senate contest will echo the national issues of foreign policy in Iraq and Afghanistan. But the really big issue of the race, he said, will be the state’s economy. “Bowles’ strongest argument in this campaign is that he’s got expe rience on the national level and that he knows how to create jobs or knows how to work the govern mental system to stimulate the creation of jobs,” Guillory said. Prior to his first Senate run, Bowles served under former President Clinton as White House chief of staff from 1996 to 1998. He is a senior adviser to Charlotte based Carousel Capital, the invest ment firm he co-founded in 1996. Paul Shumaker, Burr’s general consultant, said Bowles’ announce ment isn’t surprising, although the addition of Pierce would be “a dif ference this time around.” He added that the race will be the first statewide contest for Burr and that the representative now is focusing on solidifying his voter base and raising funds. Republicans are ready for whomever emerges from the Democratic primaries, said state GOP spokesman Jonathan Jordan. Marc Siegel, communications director for the N.C. Democratic Party, said he can’t comment on Bowles’ potential campaign strategies until he actually declares his candidacy. But he said Bowles’ impending announce ment effectively will shift the Senate contest into a higher gear. “This is a signal that the race is starting to heat up.” Contact the State 621 National Editor at stntdesk@unc.edu.